Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer. (American journal of nuclear medicine and molecular imaging, 2014)

(untitled) - Vallis, K; Reilly, R; Scollard, D; Merante, P; Brade, A; Velauthapillai, S; Caldwell, C; Chan, I; Freeman, M; Lockwood, G; Miller, N; Cornelissen, B; et al.